Catalysts
WVE Stock Catalysts
Earnings · Growth Drivers · Events · AIQ Catalyst
WVE
CatalystsStock Catalyst Board
Earnings timing, analyst expectations, news pressure, growth drivers, events, and AIQ Catalyst context.
Upcoming reporting date available for this company.
Momentum 36/100 and sentiment — before the next covered event.
Updated Sep 6, 2026 · Sentiment 26.03%
Earnings History And Surprises
See whether reported EPS and revenue have consistently exceeded or missed analyst expectations.
Earnings Expectations And Results
Compare what analysts expected with what the company reported across recent quarters.
| Report date | Fiscal period | EPS estimate | EPS actual | EPS surprise | Revenue estimate | Revenue actual |
|---|---|---|---|---|---|---|
| Jul 30, 2026 | — | -$0.30 | -$0.34 | -13.4% | $7.45M | $2.27M |
| Apr 28, 2026 | — | -$0.34 | -$0.13 | +61.8% | $8.45M | $38.25M |
| Feb 26, 2026 | — | -$0.28 | -$0.30 | -7.1% | $16.06M | $17.24M |
| Nov 10, 2025 | — | -$0.30 | -$0.32 | -6.7% | $16.35M | $7.61M |
| Jul 30, 2025 | — | -$0.29 | -$0.31 | -6.9% | $9.85M | $8.7M |
| May 8, 2025 | — | -$0.27 | -$0.29 | -7.4% | $14.42M | $9.18M |
| Mar 4, 2025 | — | -$0.17 | $0.17 | +200.0% | $12.17M | $83.75M |
| Nov 12, 2024 | — | -$0.28 | -$0.47 | -67.9% | $25.59M | -$7.68M |
Analyst Forecast And Price Targets
Wall Street consensus, rating distribution, and the current 12-month target range.
Event Read
Catalysts should explain what can change the setup, when it might happen, and which AIQ component would move first.
Current event setup
Next known earnings or reporting date.
Current analyst expectation for the upcoming report.
Current analyst expectation for the upcoming report.
News pressure around the setup.
Where event reaction would show up first.
Composite decision read before event confirmation.
Analyst context
News And Sentiment
Recent company coverage, scored where source sentiment is available.
Wave Life Sciences Second Quarter 2026 Financial Results Scheduled for July 30, 2026
CAMBRIDGE, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, will host a live webcast and conference call at 8:30 a.m. ET on Thursday, July 30, 2026, to review the company’s second quarter 2026 financial results and provide business updates.
Wave Life Sciences Announces Singapore Court Hearing, to be held on July 14, 2026 to Approve Scheme of Arrangement for Redomiciliation
CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIRE) -- As previously announced, Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health ('Wave” or 'Wave Life Sciences”), has obtained the requisite shareholder approval required in connection with its proposed redomiciliation ('Redomiciliation”) to the United States by way of the implementation of a statutory procedure known as a scheme of arrangement under Section 210 of the Companies Act 1967 of Singapore (the 'Scheme of Arrangement”). The Scheme of Arrangement remains subject to approval by the High Court of the Republic of Singapore (the 'Singapore Court”).
Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now?
Is WVE a good stock to buy? We came across a bullish thesis on Wave Life Sciences Ltd. on Biotech Distilled’s Substack. In this article, we will summarize the bulls’ thesis on WVE. Wave Life Sciences Ltd.’s share was trading at $5.70 as of June 8th. Wave Life Sciences Ltd., a clinical-stage biotechnology company, designs, develops, and […]
Related Links
WVE Catalysts FAQ
What are the next catalysts for WVE stock?
WVE's next stock catalysts can include earnings, guidance, analyst ratings, price-target changes, estimate revisions, product updates, regulatory events, contracts, or sector developments. Use this page to connect those events with AIQ and market context.
What upcoming events could move WVE stock?
Upcoming events that could move WVE include earnings reports, management commentary, estimate changes, major news, and market-wide sector catalysts.
How could WVE's next earnings report affect the stock?
WVE's next earnings report could affect the stock by changing revenue expectations, EPS estimates, guidance, analyst ratings, price targets, estimate revisions, and momentum.
What could drive WVE stock higher?
WVE could move higher if earnings, guidance, demand trends, analyst expectations, or AIQ momentum improve relative to what the market already expects.
What events could hurt WVE stock?
WVE could be hurt by weaker guidance, negative estimate revisions, margin pressure, adverse news, regulatory issues, or a sector-wide risk-off move.